drug
adapalene
Marketedupdated 3mo agoby PL Developments Copiague LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(0)
nothing on the calendar yet
Trials studying adapalene
- phase4Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
- —Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
- EP1Experience With Topical Acne Treatment
- phase4A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
- phase1A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
- phase3Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
- phase3Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 15, 2026
26 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- May 31, 2028formulationUS 79984671.8y
- Jul 18, 2027formulationUS 8071644332d
- Jul 18, 2027method-of-use (U-1078)US 8080537332d
- Jul 18, 2027method-of-use (U-1078)US 8129362332d
- Sep 15, 2026formulationUS 843550226d
- Sep 15, 2026formulationUS 870939226d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that